Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Thoratec Garners FDA Okay to Expand Heart Device Trial - Medical Product Outsourcing

Thoratec Garners FDA Okay to Expand Heart Device Trial

Pleasanton, CA-based Thoratec announced that the FDA gave its approval to add 90 more patients to a study of a new implant to regulate blood flow in heart patients. Originally, the mid-stage clinical trial for the HeartMate II called for 133 patients, of which 115 are now enrolled. Once that enrollment is complete, up to 90 more participants can be signed up for the study, which will test the effectiveness of the device. The device uses a rotary pump that regulates blood flow for long-term support of advanced-stage heart failure patients, who are ineligible for heart transplants. Thoratec already has two heart implant devices on the market and develops and markets diagnostic test systems.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters